Marital status |
Single | 1107 | 36 | 1225 | 40 | 4827 | 65 | 4982 | 67 |
Not single | 1957 | 64 | 1839 | 60 | 2591 | 35 | 2436 | 33 |
|
Income |
High | 1090 | 36 | 1052 | 35 | 1764 | 24 | 1700 | 23 |
Middle | 917 | 30 | 985 | 32 | 2838 | 38 | 2943 | 40 |
Low | 1057 | 35 | 1016 | 33 | 2816 | 38 | 2749 | 37 |
|
Previous fall during last year |
Yes | 70 | 2 | 294 | 10 | 295 | 4 | 949 | 13 |
No | 2994 | 98 | 2770 | 90 | 7123 | 96 | 6469 | 87 |
|
Economic category of the country of origin |
High income economies | 2917 | 95 | 2957 | 97 | 7067 | 95 | 7157 | 97 |
Upper middle income economies | 62 | 2 | 48 | 2 | 168 | 2 | 145 | 2 |
Lower middle income economies | 75 | 2 | 52 | 2 | 160 | 2 | 95 | 1 |
Low income economies | 6 | 0 | 3 | 0 | 15 | 0 | 12 | 0 |
|
Medication |
Opioids (NO2A) | P1* | 7 | 0 | 40 | 1 | 19 | 0 | 99 | 1 |
P2* | 133 | 4 | 199 | 7 | 416 | 6 | 634 | 9 |
P1*+P2* | 123 | 4 | 262 | 9 | 394 | 5 | 833 | 11 |
Anxiolytics/Hypnotics and Sedatives (NO5B, NO5C) | P1* | 8 | 0 | 13 | 0 | 38 | 1 | 50 | 1 |
P2* | 6 | 7 | 225 | 6 | 726 | 10 | 717 | 10 |
P1*+P2* | 390 | 13 | 606 | 20 | 1457 | 20 | 2087 | 28 |
Antidepressants (NO6A) | P1* | 1 | 0 | 9 | 0 | 10 | 0 | 12 | 0 |
P2* | 48 | 2 | 73 | 2 | 230 | 3 | 253 | 3 |
P1*+P2* | 212 | 7 | 396 | 13 | 852 | 12 | 1550 | 21 |
Psychotropic drug† | P1* | 8 | 0 | 36 | 1 | 35 | 1 | 91 | 1 |
P2* | 257 | 8 | 289 | 9 | 891 | 12 | 854 | 12 |
P1*+P2* | 587 | 19 | 988 | 32 | 2072 | 28 | 3234 | 44 |